• FirefoxInstall the new Firefox »
  •  Dow Up 0.20% Nasdaq Up 0.40%

    AcelRx Pharmaceuticals, Inc. (ACRX)

    -NasdaqGM
    9.17 Up 0.06(0.66%) 9:52AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:9.11
    Open:9.17
    Bid:9.11 x 500
    Ask:9.18 x 100
    1y Target Est:11.22
    Beta:3.03
    Next Earnings Date: 9-Mar-15ACRX Earnings announcement
    Day's Range:9.01 - 9.20
    52wk Range:5.22 - 13.64
    Volume:27,799
    Avg Vol (3m):367,960
    Market Cap:400.79M
    P/E (ttm):N/A
    EPS (ttm):-0.23
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACRX

    Comparison

    Symbol% ChgMkt Cap
    ACRXUp 0.66%400.79M
    BAXUp 0.33%37.70B
    CFNUp 0.18%12.33B
    HSPDown 0.05%15.04B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):12.21
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.95
    Quarterly EPS Est (Dec-14) :-0.30
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AcelRx Pharmaceuticals, Inc., a development stage specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain (BTP). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback